Clinical Outcomes of Patients with LAL+ in At Least One Eye

Frank A. Bucci, Jr., M.D.

Status

Invitation-only

Conditions

IOL, Cataract

Treatments

Device: Light Adjustable Lens+

Study type

Observational

Funder types

Other

Identifiers

NCT06650358

IIT-004-02

Details and patient eligibility

About

The objective of this study is to collect data on bilateral pseudophakic patients implanted with the RxSight Light Adjustable Lens+ (LAL+) in at least one eye

Full description

A retrospective-prospective, single-center study will be conducted. Patient charts will be retrospectively reviewed to collect data from the patient's comprehensive preoperative exam. Subjects will attend one stud visit post final LDD light treatment.

Enrollment

25 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

Adults with bilateral pseudophakia who have been implanted with the LAL+ in at least one eye and who have completed LDD light treatments
Sign a written Informed Consent Form

Exclusion criteria